# DESCRIPTION

## FIELD OF THE TECHNOLOGY

- relate to genome editing

## BACKGROUND

- introduce CRISPR enzymes
- describe PAM limitations
- explain PAM binding and DNA strand separation
- discuss SpCas9 PAM motif
- describe sequence limitations
- introduce alternative Cas9 variants
- discuss engineering and discovery efforts
- describe recent advances in Cas9 variants
- introduce Sc++ and SpRY Cas9 variants

## SUMMARY

- introduce SpRYc enzyme
- describe SpRYc properties
- outline potential therapeutic applications

## DETAILED DESCRIPTION

- introduce genome engineering applications of grafted ScCas9++-SpRY chimeric Cas9
- describe structure of ScCas9++ and SpRY
- motivate engineering of SpRYc by grafting PID of SpRY to N-terminus of Sc++
- describe computational modeling and experimental enzyme engineering of SpRYc
- illustrate structure of SpRYc using homology modeling
- describe in silico modeling of SpRYc
- illustrate interactions of engineered Sc++ loop with PAM region
- describe PAM characterization of SpRYc using bacterial assay
- illustrate PAM enrichment for dCas9 enzymes
- describe experimental validation of relaxed PAM specificity of SpRYc
- illustrate gating strategy for PAM-SCALAR FACS analysis
- describe human genome editing capabilities of SpRYc
- illustrate indel formation and base editing capabilities of SpRYc
- describe comparison of PAM specificities and DNA cleavage capabilities of SpRYc to SpCas9 and SpRY
- describe reduced off-target propensity of SpRYc
- illustrate off-target activity of SpRYc using GUIDE-Seq method
- describe GUIDE-Seq data
- illustrate efficiency heatmap of mismatch tolerance assay
- motivate SpRYc base editors for therapeutic applications
- describe SpRYc's ability to edit disease-associated loci
- illustrate SpRYc RTT experiment
- describe SpRYc's ability to edit Huntington's Disease loci
- illustrate SpRYc HTT experiment
- discuss limitations of PAMs in CRISPR-Cas9 immune systems
- describe SpRYc's potential for therapeutic applications
- illustrate sequencing of SpRYc sgRNA DNA constructs
- discuss development of SpRYc using in silico and in vitro PAM engineering methods
- describe materials and methods for homology modeling and plasmid generation
- describe PAM-SCANR assay
- detail plasmid library construction
- outline cell culture and DNA modification analysis
- explain GUIDE-Seq protocol
- describe Rett syndrome cell line generation
- detail TruHD cell culture
- outline statistical analysis
- discuss future in vitro and in vivo applications
- list contemplated aspects and extensions of the invention
- summarize scope of the invention

